Tendyne Holdings Overview

  • Founded
  • 2010
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 85
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $375M
Latest Deal Amount

Tendyne Holdings General Information

Description

Developer of medical device for the treatment of mitral regurgitation. The company engages in the development and commercialization of medical devices for transcatheter mitral valve replacement, repair and targeting mitral regurgitation.

Contact Information

Website
www.tendyne.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Acquirer
Primary Office
  • 2825 Fairview Avenue North
  • Roseville, MN 55113
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tendyne Holdings Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 02-Sep-2015 $375M 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 10-Mar-2014 0000 000.00 000.00 Completed Generating Revenue
4. Debt - General 07-Mar-2014 000 000.00 Completed Startup
3. Early Stage VC (Series B) 20-May-2013 000.00 000.00 0000 Completed Startup
2. Early Stage VC (Series A) 24-Feb-2012 $1.64M $1.64M 00.000 Completed Product Development
1. Seed Round Completed Startup
To view Tendyne Holdings’s complete valuation and funding history, request access »

Tendyne Holdings Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 8,034,820 $0.000100 $0.02 $0.2 $0.2 1x $0.2 10.23%
To view Tendyne Holdings’s complete cap table history, request access »

Tendyne Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of medical device for the treatment of mitral regurgitation. The company engages in the development and commer
Therapeutic Devices
Roseville, MN
85 As of 2015
000.00
0000 0000-00-00
000000&0 000.00

0000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolo
00000000000 0000000
Herzliya, Israel
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

00000 00

uis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure do
00000000000 0000000
Newtown, PA
0 As of 0000
000.00
000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tendyne Holdings Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Valcare Venture Capital-Backed Herzliya, Israel 00 000.00 00000000000 000.00
00000 000000000000 Venture Capital-Backed Newtown, PA 0 000.00 00000000000 000.00
00000000 000000000 Venture Capital-Backed Hilden, Germany 00 000.00 0000000000 0 000.00
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
0000000 Corporation Richmond, Canada 00 00000 000000000 00000
You’re viewing 5 of 12 competitors. Get the full list »

Tendyne Holdings Executive Team (7)

Name Title Board Seat Contact Info
Jeffrey Franco Chief Executive Officer, President & Board Member
Erik Kari Director, Quality and Operations
Martin Waters Executive
Dan Mans Vice President, Clinical and Therapy Development
Craig Swandal Vice President, Operations
You’re viewing 5 of 7 executive team members. Get the full list »

Tendyne Holdings Board Members (6)

Name Representing Role Since
Edward Malouf Self Board Member 000 0000
Greg Pearl Self Board Member 000 0000
Jeffrey Franco Tendyne Holdings Chief Executive Officer, President & Board Member 000 0000
Joseph Smith Self Board Member 000 0000
Kemal Schankereli Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Tendyne Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tendyne Holdings Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ATP (Apple Tree Partners) Venture Capital Minority 000 0000 000000 0
Boulle Group Angel (individual) Minority 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
To view Tendyne Holdings’s complete investors history, request access »